Evidence map›Paper›PMID 30213940›Full record

ArticleNature communications2018

SNX3-retromer requires an evolutionary conserved MON2:DOPEY2:ATP9A complex to mediate Wntless sorting and Wnt secretion.

Ian J McGough, Reinoud E A de Groot, Adam P Jellett, Marco C Betist, Katherine C Varandas, Chris M Danson, Kate J Heesom, Hendrik C Korswagen, Peter J Cullen

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 86 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. SNX-3 confers lysosomal fusion-competence to sustain basal autophagy.Cellular and molecular life sciences : CMLS · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Extracellular vesicles.Genetics · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Ian J McGoughSchool of Biochemistry, University of Bristol, Bristol, BS8 1TD, UK.ORCID http://orcid.org/0000-0002-4622-5358
Reinoud E A de GrootHubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Uppsalalaan 8, Utrecht, 3584 CT, The Netherlands.
Adam P JellettSchool of Biochemistry, University of Bristol, Bristol, BS8 1TD, UK.
Marco C BetistHubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Uppsalalaan 8, Utrecht, 3584 CT, The Netherlands.
Katherine C VarandasProgram in Cell Biology, University of California, San Francisco, 16th Street, San Francisco, CA, 94158, USA.
Chris M DansonSchool of Biochemistry, University of Bristol, Bristol, BS8 1TD, UK.
Kate J HeesomProteomics Facility, School of Biochemistry, University of Bristol, Bristol, BS8 1TD, UK.
Hendrik C KorswagenHubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Uppsalalaan 8, Utrecht, 3584 CT, The Netherlands. r.korswagen@hubrecht.eu.
Peter J CullenSchool of Biochemistry, University of Bristol, Bristol, BS8 1TD, UK. pete.cullen@bristol.ac.uk.ORCID http://orcid.org/0000-0002-9070-8349
University of Bristol · GBRoyal Netherlands Academy of Arts and Sciences · NLThe Francis Crick Institute · GBUniversity of California, San Francisco · US

Funding

Eludicating the Retromer-dependent recycling of opiod and catecholamine receptorsF31DA036290 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI VARANDAS, KATHERINE CELINA · 2013 to 2015
$105k
Biotechnology and Biological Sciences Research Council (BBSRC) BB/I011412/1KWF Kankerbestrijding (Dutch Cancer Society) HUBR 2008-4114Medical Research Council MR/P018807/1NIDA NIH HHS F31 DA036290Wellcome Trust 083474Wellcome Trust 085743Wellcome Trust 089928Wellcome Trust 104568
6 · The paper itself

Abstract

Wntless transports Wnt morphogens to the cell surface and is required for Wnt secretion and morphogenic gradients formation. Recycling of endocytosed Wntless requires the sorting nexin-3 (SNX3)-retromer-dependent endosome-to-Golgi transport pathway. Here we demonstrate the essential role of SNX3-retromer assembly for Wntless transport and report that SNX3 associates with an evolutionary conserved endosome-associated membrane re-modelling complex composed of MON2, DOPEY2 and the putative aminophospholipid translocase, ATP9A. In vivo suppression of Ce-mon-2, Ce-pad-1 or Ce-tat-5 (respective MON2, DOPEY2 and ATP9A orthologues) phenocopy a loss of SNX3-retromer function, leading to enhanced lysosomal degradation of Wntless and a Wnt phenotype. Perturbed Wnt signalling is also observed upon overexpression of an ATPase-inhibited TAT-5(E246Q) mutant, suggesting a role for phospholipid flippase activity during SNX3-retromer-mediated Wntless sorting. Together, these findings provide in vitro and in vivo mechanistic details to describe SNX3-retromer-mediated transport during Wnt secretion and the formation of Wnt-morphogenic gradients.

Indexed as

Adenosine TriphosphatasesAnimalsBiological TransportCaenorhabditis elegansEndosomesGolgi ApparatusGreen Fluorescent ProteinsHEK293 CellsHeLa CellsHumansMembrane Transport ProteinsMutationPhenotypePhospholipid Transfer ProteinsProtein BindingProtein DomainsAdenosine TriphosphatasesATP9A protein, humanDOP1B protein, humanGreen Fluorescent ProteinsMembrane Transport ProteinsMON2 protein, humanPhospholipid Transfer ProteinsProton-Translocating ATPasesSNX3 protein, humanSorting NexinsVesicular Transport ProteinsWnt Proteins

Identifiers

PMID30213940
PMCPMC6137200
OpenAlexW2889592541

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.